title: Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons.
authors.affiliation: Department of Surgery, University of Toronto, and Multi-Organ Transplant Program, Toronto General Hospital Toronto,Ontario, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Ghanekar
authors.forename: G
authors.initials: G
authors.lastname: Lajoie
authors.forename: Y
authors.initials: Y
authors.lastname: Luo
authors.forename: H
authors.initials: H
authors.lastname: Yang
authors.forename: J
authors.initials: J
authors.lastname: Choi
authors.forename: B
authors.initials: B
authors.lastname: Garcia
authors.forename: P D
authors.initials: PD
authors.lastname: Greig
authors.forename: M S
authors.initials: MS
authors.lastname: Cattral
authors.forename: E H
authors.initials: EH
authors.lastname: Cole
authors.forename: M J
authors.initials: MJ
authors.lastname: Phillips
authors.forename: C J
authors.initials: CJ
authors.lastname: Cardella
authors.forename: G A
authors.initials: GA
authors.lastname: Levy
authors.forename: R
authors.initials: R
authors.lastname: Zhong
authors.forename: D R
authors.initials: DR
authors.lastname: Grant
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D015703:Antigens, CD / Q000235:genetics; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D018958:CD55 Antigens / Q000235:genetics*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D010215:Papio; D011817:Rabbits; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D000961:Antilymphocyte Serum; D018958:CD55 Antigens; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide